Horizon Pharma withdraws offer for Depomed after court ruling

Nov 19 (Reuters) - Ireland-based Horizon Pharma Plc said it has withdrawn its offer to acquire Depomed Inc following a court ruling that granted Depomed's motion for preliminary injunctive relief on Horizon's alleged used of confidential information.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.